These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 29657012)
1. Antiprotozoal treatment of canine babesiosis. Baneth G Vet Parasitol; 2018 Apr; 254():58-63. PubMed ID: 29657012 [TBL] [Abstract][Full Text] [Related]
2. Babesiosis in dogs and cats--expanding parasitological and clinical spectra. Solano-Gallego L; Baneth G Vet Parasitol; 2011 Sep; 181(1):48-60. PubMed ID: 21571435 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy against babesiosis. Vial HJ; Gorenflot A Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402 [TBL] [Abstract][Full Text] [Related]
5. Frequency and therapy monitoring of canine Babesia spp. infection by high-resolution melting curve quantitative FRET-PCR. Wang C; Ahluwalia SK; Li Y; Gao D; Poudel A; Chowdhury E; Boudreaux MK; Kaltenboeck B Vet Parasitol; 2010 Feb; 168(1-2):11-8. PubMed ID: 19931290 [TBL] [Abstract][Full Text] [Related]
6. Anti-babesial activity of a series of 6,7-dimethoxyquinazoline-2,4-diamines (DMQDAs). Ji S; Rizk MA; Galon EM; El-Alfy ES; Mizukawa Y; Kojima M; Ikegami-Kawai M; Kaya M; Liu M; Itoh I; Xuan X Acta Trop; 2024 Jan; 249():107069. PubMed ID: 37952866 [TBL] [Abstract][Full Text] [Related]
7. Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin. Di Cicco MF; Downey ME; Beeler E; Marr H; Cyrog P; Kidd L; Diniz PP; Cohn LA; Birkenheuer AJ Vet Parasitol; 2012 Jun; 187(1-2):23-7. PubMed ID: 22305297 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation of Babesia gibsoni infection from a pit-bull terrier pup recently imported into South Africa. Matjila PT; Penzhorn BL; Leisewitz AL; Bhoora R; Barker R J S Afr Vet Assoc; 2007 Mar; 78(1):2-5. PubMed ID: 17665757 [TBL] [Abstract][Full Text] [Related]
9. Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni. Lin MY; Huang HP Acta Vet Scand; 2010 Apr; 52(1):27. PubMed ID: 20416095 [TBL] [Abstract][Full Text] [Related]
10. Babesia negevi infection in dogs and response to treatment. Salant H; Nachum-Biala Y; Zivotofsky D; Tzur TE; Baneth G Ticks Tick Borne Dis; 2024 Jan; 15(1):102282. PubMed ID: 37989015 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro. Hwang SJ; Yamasaki M; Nakamura K; Sasaki N; Murakami M; Wickramasekara Rajapakshage BK; Ohta H; Maede Y; Takiguchi M J Vet Med Sci; 2010 Jun; 72(6):765-71. PubMed ID: 20160418 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs. Kirk SK; Levy JK; Crawford PC J Vet Intern Med; 2017 Jul; 31(4):1108-1112. PubMed ID: 28625019 [TBL] [Abstract][Full Text] [Related]
13. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. Sakuma M; Setoguchi A; Endo Y J Vet Intern Med; 2009; 23(3):493-8. PubMed ID: 19645835 [TBL] [Abstract][Full Text] [Related]
14. Repeated imidocarb treatment failure suggesting emerging resistance of Babesia canis in a new endemic area in north-eastern Germany. Weingart C; Krücken J; Kohn B Ticks Tick Borne Dis; 2024 May; 15(3):102315. PubMed ID: 38301344 [TBL] [Abstract][Full Text] [Related]
15. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene. Penzhorn BL; Lewis BD; de Waal DT; López Rebollar LM J S Afr Vet Assoc; 1995 Sep; 66(3):157-9. PubMed ID: 8596187 [TBL] [Abstract][Full Text] [Related]
16. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate. Brandão LP; Hagiwara MK; Myiashiro SI Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. Birkenheuer AJ; Levy MG; Breitschwerdt EB J Vet Intern Med; 2004; 18(4):494-8. PubMed ID: 15320586 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. Pudney M; Gray JS J Parasitol; 1997 Apr; 83(2):307-10. PubMed ID: 9105316 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Matsuu A; Koshida Y; Kawahara M; Inoue K; Ikadai H; Hikasa Y; Okano S; Higuchi S Vet Parasitol; 2004 Sep; 124(1-2):9-18. PubMed ID: 15350657 [TBL] [Abstract][Full Text] [Related]
20. Clindamycin in the treatment of Babesia gibsoni infections in dogs. Wulansari R; Wijaya A; Ano H; Horii Y; Nasu T; Yamane S; Makimura S J Am Anim Hosp Assoc; 2003; 39(6):558-62. PubMed ID: 14736722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]